DEA prescribing for a dentist: the three-year registration, what 21 CFR 1306.05 requires on the face of a prescription, and the rules by schedule

What it says#

Three sets of rules govern a dentist's controlled substance prescribing: registration in 21 CFR part 1301, the prescription itself in part 1306, and electronic prescribing in part 1311.

Registration comes first. 21 CFR 1306.03 says a prescription may be issued only by an individual practitioner who is authorized to prescribe controlled substances by the jurisdiction where they are licensed and who is either registered or exempt from registration. The registration table in 1301.13(e) sets the terms for a dentist: the dispensing category covers Schedules II through V, the new application is DEA Form 224 and the renewal is 224a, the application fee is $888, and the registration period is three years. A registrant may apply to be reregistered no more than 60 days before expiration.

Then the prescription. 1306.04(a) is the substantive rule: to be effective, a prescription must be issued for a legitimate medical purpose by an individual practitioner acting in the usual course of professional practice, and a corresponding responsibility rests with the pharmacist who fills it. 1306.05(a) is the formal one and lists what has to appear: the date, the signature on the day of issue, the patient's full name and address, the drug name, strength, dosage form, quantity prescribed, directions for use, and the prescriber's name, address and registration number. A paper prescription must be manually signed, and 1306.05(d) says that a computer-generated prescription printed or faxed by the practitioner must be manually signed too. A staff member may prepare the prescription for signature under 1306.05(f), but the prescriber remains responsible if it does not conform.

The rules then split by schedule. A Schedule II drug requires a written prescription signed by the practitioner, or an electronic one; it may be faxed, but except in three narrow situations the original manually signed paper has to reach the pharmacist before dispensing. Refilling a Schedule II prescription is prohibited outright. Instead, 1306.12(b) lets a practitioner issue multiple prescriptions totaling up to a 90-day supply, provided each is for a legitimate medical purpose, each one after the first carries written instructions giving the earliest date a pharmacy may fill it, the practitioner concludes this creates no undue risk of diversion or abuse, and state law permits it. In an emergency a Schedule II may be authorized orally for the quantity adequate to treat the patient during the emergency period, with a written prescription delivered to the pharmacist within seven days and the words "Authorization for Emergency Dispensing" on its face.

Schedules III, IV and V are looser at issuance: a signed paper prescription, a fax of one, a compliant electronic prescription, or an oral order the pharmacist promptly reduces to writing. Refills are capped: no Schedule III or IV prescription may be filled or refilled more than six months after the date of issue, and none may be refilled more than five times. An oral refill authorization is allowed inside that cap, and anything beyond it needs a new prescription.

Part 1311 governs the electronic route. 1306.05(e) requires an electronic prescription to be created and signed in an application meeting part 1311, and 1311.100(c) says a prescription created in an application that does not meet those requirements is not a valid prescription. Signing requires two of three factors under 1311.115: something the practitioner knows, something they are, or a hard token separate from the computer that meets at least FIPS 140-2 Security Level 1. 1311.102 puts the duty on the dentist personally: retain sole possession of the token, never share the password or biometric, and report a lost, stolen or compromised credential within one business day of discovery, because a practitioner who does not may be held responsible for prescriptions written with it, and a failure to secure it can support revocation or suspension under 21 U.S.C. 824(a)(4).

Who it applies to#

Every dentist who writes for a controlled substance, and the practice that employs them. A dentist with no DEA registration has nothing to comply with here until they apply for one. A separate one-time obligation attaches at registration or renewal: eight hours of training on treating and managing patients with substance use disorders, attested on the form, which the reference entry at dea-mate-act-training covers in full and this entry does not repeat.

Two administrative rules catch owners out. First, termination. Under 1301.52(a), a registration terminates without any further action by DEA when the registrant dies, ceases legal existence, discontinues professional practice or surrenders it, and a surrender is effective when any DEA employee receives a signed DEA Form 104 or any signed writing expressing the desire to surrender. Second, transfer. No registration or authority under it may be assigned or otherwise transferred except on conditions DEA specifically designates and then only with written consent, requested in writing with full details. Where a practice changes hands and the stock of controlled substances goes with it, 1301.52(d) requires notice to the DEA Special Agent in Charge at least 14 days before the transfer, naming both registrants, the location, and the date; the inventory taken on the transfer date serves as the transferor's final inventory and the transferee's initial one. A change of name, address or schedules is not a transfer at all: it is a modification under 1301.51, handled online with no fee.

What changed#

One line of the prescription rule disappeared this summer. DEA's final rule at 91 FR 34754, published June 9, 2026 and effective July 9, 2026, removed and reserved 21 CFR 1306.05(b), which had required a prescription for a Schedule III, IV or V narcotic approved for detoxification or maintenance treatment to carry the identification number issued under the old DATA-waiver rules. Congress had already eliminated the waiver in the December 2022 omnibus, the same act whose Section 1263 created the eight-hour training condition, and this rule finished the cleanup. Few dentists wrote those prescriptions, but the regulation is now shorter by a paragraph and 1306.04 reads affirmatively.

The renewal process has also changed since 2020 and still surprises people. DEA no longer mails renewal notices. An electronic reminder goes to the email address on the registration at 60, 45, 30, 15 and 5 days before expiration, and applications and renewals are submitted online. If a renewal is filed in time, the registrant may keep operating past the expiration date until DEA acts. If it is not, DEA allows reinstatement for one calendar month after expiration; after that a new registration is required. Either way, federal law prohibits handling controlled substances for any period under an expired registration.

Where the source is#

The regulations are on eCFR: 21 CFR part 1301 for registration, modification, termination and transfer; part 1306 for prescriptions, including 1306.05 on the face of the prescription, 1306.11 through 1306.13 for Schedule II and 1306.21 through 1306.23 for Schedules III, IV and V; and part 1311 for electronic prescribing. The DEA Diversion Control Division's registration page carries the renewal and reinstatement policy quoted here and links the online forms, and its EPCS page collects the electronic prescribing rules and notices. The June 2026 final rule is on govinfo at 91 FR 34754. State law is frequently stricter than these federal floors on quantity limits, prescription monitoring program checks and mandatory e-prescribing, and none of that is reported here.